Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Top Scholars from Home and Abroad Gather at CCHIO&AOS Oncology Event, Planning Cancer Prevention and Control and Integrated Diagnosis and Treatment with a Global Perspective!

    Uniting China, Linking the World. From November 14-17, the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) and the 4th Asian Oncology Society (AOS) were held concurrently in Xi’an, bringing an academic feast to the Chinese medical community and providing an opportunity for in-depth exchange and cooperation in the global oncology field. The conference covered…

    2025.02.18
  • National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part I

    Healthy living for all, together we uphold, and start a new chapter! September is the National Healthy Lifestyle Promotion Month. We focus on breast cancer, a significant disease threatening women’s health, and have specially invited authoritative experts in the field of breast cancer from China to discuss the scientific prevention and treatment of breast cancer…

    2025.02.18
  • Professor Yehui Shi: The Epigenetic Regulation of HR+ Metastatic Breast Cancer—A Review of the Development Path of HDACi Entinostat

    Histone deacetylases (HDACs) are overexpressed in various tumors and are closely related to tumor progression and drug resistance. In hormone receptor-positive (HR+) breast cancer, HDAC overexpression leads to resistance to endocrine therapy and CDK4/6 inhibitors. The targeted application of HDAC inhibitors (HDACi) can effectively block this process, bringing better prognosis to patients. Entinostat, introduced in…

    2025.02.18
  • World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (2)

    Breast cancer is one of the most common malignant tumors in women and is often referred to as the “pink killer,” posing a serious threat to women’s health. The World Health Organization has designated October as “World Breast Cancer Awareness Month” (also known as Pink Ribbon Month) to raise women’s awareness of breast cancer prevention.…

    2025.02.18
  • World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (1)

    Breast cancer is one of the most common malignant tumors in women and is often referred to as the “pink killer,” posing a serious threat to women’s health. The World Health Organization has designated October as “World Breast Cancer Awareness Month” (also known as Pink Ribbon Month) to raise women’s awareness of breast cancer prevention.…

    2025.02.18
  • Global Trends in HBV-Related Liver Cancer: A Growing Concern

    Published on February 11, 2025, in Hepatology, this study sheds light on the persistent global burden of hepatitis B virus (HBV)-related liver cancer. While significant progress has been made in…

    2025.02.18
  • SABCS 2024 | Prof. Charles Geyer: NSABP B-59—Atezolizumab in Neoadjuvant Triple-Negative Breast Cancer

    Oncology Frontier: Please share the key findings of the NSABP B-59/GBG-96-GeparDouze study. In particular, what are the highlights regarding the efficacy and safety of atezolizumab when added to neoadjuvant chemotherapy…

    2025.02.18
  • SABCS 2024 | Professor Janice Tsang: Looking Back at 2024, Sharing Highlight Studies and Insights in Early-Stage Breast Cancer

    Oncology Frontier:You introduced “Early Breast Cancer Updates” in Year in Review session. Please review the lecture and tell us about the research progress in the field of early breast cancer…

    2025.02.18
«previous next»
Recent Posts
  • Professor Thomas Powles: How Will ADC–Immunotherapy Combinations and ctDNA Reshape Perioperative Treatment in Bladder Cancer?
  • Professor Xieqiao Yan: Optimizing Post-Failure Treatment Strategies in Renal Cell Carcinoma After Targeted-Immunotherapy—Exploring New Pathways for Later-Line Therapy
  • Professor Ludong Qiao Interprets the IDSA Guidelines on Complicated Urinary Tract Infections: Rational Use of Cefiderocol and Novel Antibiotic Combinations
  • Professor Yonghong Li: Neoadjuvant Therapy for Locally Advanced Prostate Cancer—A Chinese Perspective and Clinical Balance
  • Research Breakthrough by Professor Qiang Lü’s Team at Jiangsu Provincial People’s Hospital: Imaging AI Enables Personalized Prognosis Prediction and Treatment Response Assessment in Bladder Cancer
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top